EMVL:LSE:LSE-iShares Edge MSCI EM Value Factor UCITS ETF USD (Acc) (USD)

ETF | Others |

Last Closing

USD 51.495

Change

-0.05 (-0.09)%

Market Cap

USD 0.34B

Volume

2.74K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.13 (-0.05%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

-20.50 (-0.11%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+2.75 (+1.42%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.22 (-1.20%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.22 (-1.55%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

+1.37 (+1.27%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.37 (-1.21%)

USD 260.39B
0QZO:LSE 0QZO

-4.20 (-4.09%)

USD 258.54B

ETFs Containing EMVL:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.78% 72% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.78% 71% C- 66% D+
Trailing 12 Months  
Capital Gain 12.26% 85% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.26% 84% B 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.43% 56% F 61% D-
Dividend Return 8.43% 55% F 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.36% 58% F 75% C
Risk Adjusted Return 68.23% 66% D+ 79% B-
Market Capitalization 0.34B 66% D+ 38% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike